DZ Bank Aktienanleihe OMV 30.12.2.../ DE000DQ99KY6 /
23/12/2024 9:00:12 | Diferencia-0.38 | Bid10:43:11 | Ask10:43:11 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
94.96EUR | -0.40% | 94.62 Volumen de oferta: 200,000 |
94.72 Tamaño/ Volumen/ Formato de Ask: 200,000 |
OMV AG | 37.50 EUR | 30/12/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- Primera página
- Atrás
- 1
- 2
- Siguiente
- Última página